NCT02741570 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 472
- group Id
- BG001
- value
- 475
- group Id
- BG002
- value
- 947
- units
- Participants
- groups
- description
- Nivolumab 3 mg/kg IV every 2 weeks + Ipilimumab 1 mg/kg IV every 6 weeks until progression, unacceptable toxicity, or a maximum of 24 months from first nivolumab treatment.
- id
- BG000
- title
- Nivolumab + Ipilimumab
- description
- Cetuximab 400 mg/m2 IV for the initial dose only, then 250 mg/m2 weekly + cisplatin (100mg/m2) or carboplatin (AUC of 5 mg per milliliter per minute) on Day 1 and fluorouracil (1000 mg/m2 per day for 4 days) every 3 weeks for maximum of 6 cycles followed by maintenance cetuximab at 250 mg/m2 weekly (or every 2 weeks, per local prescribing information) until disease progression or unacceptable toxicity; the choice of cisplatin or carboplatin is at the discretion of the investigator.
- id
- BG001
- title
- EXTREME Regimen
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.7
- value
- 60.4
- group Id
- BG001
- spread
- 9.5
- value
- 60.9
- group Id
- BG002
- spread
- 9.6
- value
- 60.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 310
- group Id
- BG001
- value
- 295
- group Id
- BG002
- value
- 605
- title
- < 65
- measurements
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 285
- title
- >= 65 AND < 75
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 54
- title
- >= 75 AND < 85
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- >= 85
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 170
- title
- Female
- measurements
- group Id
- BG000
- value
- 380
- group Id
- BG001
- value
- 397
- group Id
- BG002
- value
- 777
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 83
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 406
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 233
- group Id
- BG001
- value
- 225
- group Id
- BG002
- value
- 458
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 12
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 113
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 22
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 379
- group Id
- BG001
- value
- 401
- group Id
- BG002
- value
- 780
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 19
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 472
- group Id
- BG001
- value
- 475
- group Id
- BG002
- value
- 947
- units
- Participants
- groups
- description
- Nivolumab 3 mg/kg IV every 2 weeks + Ipilimumab 1 mg/kg IV every 6 weeks until progression, unacceptable toxicity, or a maximum of 24 months from first nivolumab treatment.
- id
- BG000
- title
- Nivolumab + Ipilimumab
- description
- Cetuximab 400 mg/m2 IV for the initial dose only, then 250 mg/m2 weekly + cisplatin (100mg/m2) or carboplatin (AUC of 5 mg per milliliter per minute) on Day 1 and fluorouracil (1000 mg/m2 per day for 4 days) every 3 weeks for maximum of 6 cycles followed by maintenance cetuximab at 250 mg/m2 weekly (or every 2 weeks, per local prescribing information) until disease progression or unacceptable toxicity; the choice of cisplatin or carboplatin is at the discretion of the investigator.
- id
- BG001
- title
- EXTREME Regimen
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.7
- value
- 60.4
- group Id
- BG001
- spread
- 9.5
- value
- 60.9
- group Id
- BG002
- spread
- 9.6
- value
- 60.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 310
- group Id
- BG001
- value
- 295
- group Id
- BG002
- value
- 605
- title
- < 65
- measurements
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 285
- title
- >= 65 AND < 75
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 54
- title
- >= 75 AND < 85
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- >= 85
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 170
- title
- Female
- measurements
- group Id
- BG000
- value
- 380
- group Id
- BG001
- value
- 397
- group Id
- BG002
- value
- 777
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 83
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 406
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 233
- group Id
- BG001
- value
- 225
- group Id
- BG002
- value
- 458
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 12
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 113
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 22
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 379
- group Id
- BG001
- value
- 401
- group Id
- BG002
- value
- 780
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 19
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle